fibrinogen has been researched along with Vascular Malformations in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Gu, H; Hu, L; Lin, X; Liu, H; Xu, Z; Yang, X | 1 |
| Becker, F; Blaise, S; Desmurs-Clavel, H; Jeancolas, J; Jurus, C; Laaeng Massoni, C; Laroche, JP; Maloizel-Delaunay, J; Mestre-Godin, S; Nou-Howaldt, M; Pichot, O; Sarlon-Bartoli, G; Sevestre-Pietri, MA; Soulier-Sotto, V; Thiel, H | 1 |
| Crary, SE; Mack, JM; Richter, GT | 1 |
| Ardillon, L; Boon, LM; Eeckhoudt, S; Hermans, C; Lambert, C | 1 |
| Aguado, L; Cabrera, J; Marquina, M; Martínez-Cuesta, A; Paramo, JA; Redondo, P; Sánchez-Ibarrola, A; Sierra, A | 1 |
| Aguado, L; Redondo, P; Rodríguez-Mañero, M | 1 |
| Bresser, P; Douma, RA; Gerdes, VE; Oduber, CE; van Beers, EJ; van der Horst, CM | 1 |
7 other study(ies) available for fibrinogen and Vascular Malformations
| Article | Year |
|---|---|
Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations.
Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Child; Dabigatran; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Pain; Retrospective Studies; Vascular Malformations | 2023 |
[Quality standards for ultrasonographic assessment of peripheral vascular malformations and vascular tumors. Report of the french society for vascular medicine. 2018 Update].
Topics: Adult; Blood Coagulation Disorders; Blood Flow Velocity; Clinical Competence; Disease Progression; Eye Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemangioma; Hemodynamics; Humans; Infant; Lymphangioma, Cystic; Male; Quality Assurance, Health Care; Ultrasonography, Doppler, Color; Ultrasonography, Doppler, Duplex; Vascular Malformations; Vascular Neoplasms | 2018 |
Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series.
Topics: Administration, Oral; Adolescent; Adult; Anticoagulants; Blood Coagulation Disorders; Blood Flow Velocity; Factor Xa Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Pain; Rivaroxaban; Treatment Outcome; Vascular Malformations; Young Adult | 2018 |
Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations.
Topics: Adult; Anticoagulants; Blood Platelets; Dabigatran; Disseminated Intravascular Coagulation; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Platelet Count; Thrombosis; Vascular Malformations | 2016 |
Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies.
Topics: Adolescent; Adult; Angiogenic Proteins; Biomarkers; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Blood Flow Velocity; Female; Fibrinogen; Humans; Klippel-Trenaunay-Weber Syndrome; Male; Syndrome; Vascular Malformations; Young Adult | 2010 |
Pulmonary arterial hypertension in patients with slow-flow vascular malformations.
Topics: Adolescent; Adult; Blood Flow Velocity; Child; Child, Preschool; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Hypertension, Pulmonary; Lymphatic Vessels; Male; Middle Aged; Pulmonary Wedge Pressure; Retrospective Studies; Ultrasonography, Doppler; Vascular Malformations; Veins; von Willebrand Factor; Young Adult | 2010 |
Extensive slow-flow vascular malformations and pulmonary hypertension.
Topics: Blood Flow Velocity; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension, Pulmonary; Lymphatic Vessels; Pulmonary Wedge Pressure; Ultrasonography, Doppler; Vascular Malformations; Veins; von Willebrand Factor | 2010 |